Reporter Nov 11 2022

Study finds inherited link to appendix cancer

Nov. 11, 2022—A Vanderbilt study is the first to show inherited risk factors for appendiceal cancer.

National Injury Prevention Day set for Nov. 18

Nov. 11, 2022—National Injury Prevention Day, Nov. 18, highlights need for awareness

Gastric Cancer Foundation funds Eunyoung Choi research

Nov. 10, 2022—The Gastric Cancer Foundation has awarded a one-year $100,000 research grant to Eunyoung Choi, PhD, to support her efforts to find a way to disrupt the transformation of dysplastic stem cells into stomach cancer.

Entrances to VUMC facilities to remain secured

Nov. 10, 2022—VUMC is keeping most entrance points to its facilities secured in the same way they have been for the previous two-plus years.

AstraZeneca VP to discuss COVID-19 collaboration with VUMC Nov. 17

Nov. 10, 2022—On Thursday, Nov. 17, Mark Esser, PhD, vice president, Early Vaccines and Immune Therapies R&D at AstraZeneca, will discuss his company’s collaboration with Vanderbilt University Medical Center that led to development of the Evusheld antibody combo to prevent COVID-19 in high-risk individuals.

Jacek Hawiger, MD, PhD, third from right, with study team members, from left, Katherine Gibson-Corley, DVM, PhD, Yan Liu, MD, Jozef Zienkiewicz, PhD, Huan Qiao, MD, PhD, and Ruth Ann Veach.

Hawiger still blazing a trail in inflammation research

Nov. 10, 2022—Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema.

After two surgeries to remove tumors from her spine, patient Reagan Brown can walk freely again and has no limitations.

Spinal surgeries help restore young patient’s mobility

Nov. 10, 2022—by Nancy Humphrey Reagan Brown was 7 years old in 2015 when she started dragging her right leg as she walked. Her parents took her to a chiropractor, then an orthopaedic specialist in her hometown of Mt. Juliet, Tennessee, who recommended physical rehabilitation. But her gait worsened, and she was referred to Steven Lovejoy, MD,...

The clinical trial group includes, from left, Gordon Bernard, MD, Katherine Cahill, MD, Kevin Niswender, MD, PhD, Pingsheng Wu, PhD, and R. Stokes Peebles, MD.

Clinical trial at VUMC tests novel treatment for asthma

Nov. 10, 2022—VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.

Study explores CVD risk for people with HIV

Nov. 10, 2022—A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.

Study defines role of steroids in congenital heart disease surgery

Nov. 10, 2022—Steroids are commonly given to infants during open-heart surgery to reduce inflammation, but whether the drugs significantly improve patient outcomes has not been settled — until now.

Kennedy Center seeks participants for disabilities research learning sessions

Nov. 10, 2022—In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD.

Study to explore nasal bacteria of children born by C-section

Nov. 10, 2022—Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.